PV pharm branch, vendor, cage 0U9U0

Ended Awarded Last action

Contract number
SPE2D826F09F3
Awardee
Awarding agency
Obligated
$207,133

Award facts

Contract value 100% obligated
$207,133.05 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 28, 2026, valued at $207,133.05 under a firm fixed-price contract with the Defense Logistics Agency Medical Supply Chain. The order is non-set-aside and competitively awarded, with performance to be completed by January 29, 2026, at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, medical devices, and test kits to support military healthcare programs worldwide.

AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts demonstrates its established capability to meet Defense Logistics Agency medical procurement requirements across multiple therapeutic domains, including diabetes treatments, neurological medications, pain management products, and antibiotics. The contractor's consistent performance on competitively awarded delivery orders with firm fixed pricing—ranging from modest transactions to orders exceeding $45,000—reflects its ability to reliably supply essential medical commodities to military treatment facilities, veterans' healthcare systems, and other federal medical institutions. The Defense Logistics Agency has indicated plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the strategic suppliers supporting the agency's medical supply chain objectives.

Quick answers

Who was awarded contract SPE2D826F09F3?

SPE2D826F09F3 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 28, 2026.

How much is contract SPE2D826F09F3 worth?

The government has obligated $207,133 on SPE2D826F09F3.

Is contract SPE2D826F09F3 an order under another contract?

Yes. SPE2D826F09F3 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.

Was contract SPE2D826F09F3 competed?

The extent of competition for SPE2D826F09F3 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award